Toronto, April 22, 2024 /CNW/ – Vayiz, an exciting startup in innovative AI-driven medical imaging solutions, today announced the launch of its breakthrough product PTLC – Mark 1. This advanced medical diagnostic software utilizes cutting-edge artificial intelligence to highly accurately assess pneumonia, tuberculosis, and lung cancer, achieving superior diagnostic accuracy of up to 94.8%.
Innovative technology that transforms medical imaging
PTLC – Mark 1 represents a major advance in the fight against respiratory diseases and provides healthcare providers with a reliable tool. This cutting-edge technology not only increases diagnostic accuracy but also significantly improves patient outcomes by facilitating early and accurate detection.
A personal mission to fight misdiagnosis
At Vayiz, our commitment to innovation and improvement in medical diagnostics is a deeply personal one, spearheaded by founder Shavayiz Malik. This journey began in response to a series of personal misdiagnoses that affected Shavaiz’s closest family.
Shavayiz Malik, Founder, CEO and CTO of Vayiz said: “These deeply personal experiences ignited my passion to expose the devastating consequences of medical misdiagnosis and leverage cutting-edge technology to effect positive change.” “PTLC – With the development of Mark 1, Vayiz is setting a new standard in healthcare, ensuring patients receive the correct diagnosis the first time.”
We are united by our mission to transform medical diagnostics. Our technology is designed not only to detect diseases with high precision, but also to ensure that such innovations lead to measurable improvements in patient care around the world. Our company is driven by a commitment to excellence, a spirit of innovation, and a dedication to saving lives and improving health outcomes through superior diagnostic accuracy.
Introducing the team that supports innovation
The team at Vayiz is driven by a shared commitment to innovation and excellence in healthcare. Our CEO and CTO, Shavayiz Malik, brings a wealth of experience from the technology and financial sectors to spearhead our technological advancements. Abdul Muttal SharifOur COO, , leverages deep integration management expertise to ensure operational excellence and strategic growth.
Join the diagnostic revolution
Vayiz is forging partnerships and moving forward to bring PTLC – Mark 1 to hospitals and clinics around the world. We invite you to join us on this journey of transformation.
For more information about Vayiz and PTLC – Mark 1, please visit https://vayiz.com/.
Source: Vise
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/22/c9343.html
